533573 Stock Overview
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Alembic Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹965.20 |
| 52 Week High | ₹1,093.05 |
| 52 Week Low | ₹527.35 |
| Beta | 0.69 |
| 1 Month Change | 0.12% |
| 3 Month Change | 2.68% |
| 1 Year Change | 82.23% |
| 3 Year Change | -3.02% |
| 5 Year Change | 82.11% |
| Change since IPO | 2,002.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| 533573 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.8% | -2.8% | -1.5% |
| 1Y | 82.2% | 54.9% | 45.0% |
Return vs Industry: 533573 exceeded the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: 533573 exceeded the Indian Market which returned 45% over the past year.
Price Volatility
| 533573 volatility | |
|---|---|
| 533573 Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 533573 has not had significant price volatility in the past 3 months.
Volatility Over Time: 533573's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1907 | 14,593 | Chirayu Amin | alembicpharmaceuticals.com |
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products.
Alembic Pharmaceuticals Limited Fundamentals Summary
| 533573 fundamental statistics | |
|---|---|
| Market cap | ₹189.80b |
| Earnings (TTM) | ₹5.90b |
| Revenue (TTM) | ₹61.18b |
32.2x
P/E Ratio3.1x
P/S RatioIs 533573 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 533573 income statement (TTM) | |
|---|---|
| Revenue | ₹61.18b |
| Cost of Revenue | ₹18.34b |
| Gross Profit | ₹42.84b |
| Other Expenses | ₹36.94b |
| Earnings | ₹5.90b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 30.03 |
| Gross Margin | 70.02% |
| Net Profit Margin | 9.65% |
| Debt/Equity Ratio | 19.4% |
How did 533573 perform over the long term?
See historical performance and comparison